Usefulness of Preprocedural N-Terminal Pro-Brain Natriuretic Peptide in Predicting Angiographic No-Reflow Phenomenon During Stent Implantation in Patients With ST-Segment Elevation Acute Myocardial Infarction

American Journal of Cardiology

Volumn 100, Issue 4, 2007, Pages 631-634

  Hong, Seo Na ^a   Ahn, Youngkeun ^a   Hwang, Sun Ho ^a   Yoon, Nam Sik ^a   Lee, Sang Rok ^a   Moon, Jae Youn ^a   Kim, Kye Hun ^a   Hong, Young Joon ^a   Park, Hyung Wook ^a   Kim, Ju Han ^a   Jeong, Myung Ho ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION; STENT; THORAX PAIN;

BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREOPERATIVE CARE; PROGNOSIS; PROTEIN PRECURSORS; ROC CURVE; STENTS; SURVIVAL RATE;

EID: 34547687775     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.075     Document Type: Article

References (16)

1. The GUSTO Angiographic Investigators. The effect of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 361 (2003) 13-20
3. Morishima I., Sone T., Okumura K., Tsuboi H., Kondo J., Mukawa H., Matsui H., Toki Y., Ito T., and Hayakawa T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000) 1202-1209
4. Stone G.W., Peterson M.A., Lansky A.J., Dangas G., Mehran R., and Leon M.B. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 39 (2002) 591-597
5. Rezkalla S.H., and Kloner R.A. No-reflow phenomenon. Circulation 105 (2002) 656-662
6. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., Barnathan E.S., Califf R., Topol E.J., Simoons M.L., and Wallentin L. N-Terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 108 (2003) 275-281
7. Thompson P.L., Meredith I., Amerena J., Campbell T.J., Sloman J.G., and Harris P.J. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J 148 (2004) e1-e8
8. Reffelmann T., and Kloner R.A. The no-reflow phenomenon: basic science and clinical correlates. Heart 87 (2002) 162-168
9. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3 (2006) 499-506
10. Omland T., de Lemos J.A., Morrow D.A., Antman E.M., Cannon C.P., Hall C., and Braunwald E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89 (2002) 463-465
11. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., Harrford M., and Caidahl K. N-Terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
12. Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., White H.D., and Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-Terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
13. Hong S.N., Yoon N.S., Ahn Y., Lim S.Y., Kim Y.S., Yun K.H., Kang D.K., Lee S.H., Lee Y.S., Kim K.H., et al. N-Terminal pro-B-type natriuretic peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes. Circ J 69 (2005) 1472-1476
14. Hong S.N., Ahn Y., Yoon N.S., Lee K.H., Kim Y.S., Hwang S.H., Lee S.R., Kim K.H., Park H.W., Hong Y.J., et al. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Am J Cardiol 99 (2007) 1051-1054
15. Grabowski M., Filipiak K.J., Karpinski G., Wretowski D., Rdzanek A., Huczek Z., Horszczaruk G.J., Kochman J., Rudowski R., and Opolski G. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Am Heart J 148 (2004) 655-662
16. Di Bella G., Aquaro G.D., Strata E., Deiana M., De Marchi D., Lombardi M., and Pingitore A. Simultaneous visualization of myocardial scar, no-reflow phenomenon, ventricular and atrial thrombi by cardiac magnetic resonance. Int J Cardiol 115 (2007) e10-e11